VIVUS Inc.

VIVUS Inc. and Medpace Inc. entered into a Master Services Agreement and three Task Orders thereunder pursuant to which Medpace will perform certain clinical research services in connection with the Phase 3 clinical trials through 2009 for Qnexa, the Company's investigational product candidate for the treatment of obesity.